{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T06:53:40Z","timestamp":1770274420640,"version":"3.49.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T00:00:00Z","timestamp":1710201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T00:00:00Z","timestamp":1710201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA054993"],"award-info":[{"award-number":["R01DA054993"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA054993"],"award-info":[{"award-number":["R01DA054993"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA054993"],"award-info":[{"award-number":["R01DA054993"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA054993"],"award-info":[{"award-number":["R01DA054993"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA054993"],"award-info":[{"award-number":["R01DA054993"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA054993"],"award-info":[{"award-number":["R01DA054993"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA054993"],"award-info":[{"award-number":["R01DA054993"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA054993"],"award-info":[{"award-number":["R01DA054993"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA054993"],"award-info":[{"award-number":["R01DA054993"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["K23AA028515"],"award-info":[{"award-number":["K23AA028515"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["5UL1TR001863"],"award-info":[{"award-number":["5UL1TR001863"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["5UL1TR001863"],"award-info":[{"award-number":["5UL1TR001863"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Menthol cigarette use remains a large public health problem and disproportionately affects Black adults in the United States. The Food and Drug Administration has proposed prohibiting menthol flavor in cigarettes to protect public health. However, e-cigarettes are available in menthol flavor and are a popular alternative product adults might switch to if menthol is prohibited in cigarettes. Research is needed to understand how availability of menthol (vs. tobacco) flavored e-cigarettes could impact cigarette use among adults who smoke menthol cigarettes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We will recruit 150 adults who currently smoke menthol cigarettes and will randomize them to 1 of 3 conditions modeling different regulatory scenarios. We will recruit equal numbers of participants identifying as Black vs. non-Black and will stratify randomization by race. To promote standardization and adherence, cigarette and e-cigarette products will be provided for 8 weeks based on the assigned condition: (A) no menthol restriction (menthol cigarette and menthol flavored e-cigarette), (B) menthol prohibited in cigarettes only (non-menthol cigarette and menthol flavored e-cigarette), (C) menthol prohibited in both cigarettes and e-cigarettes (non-menthol cigarette and tobacco flavored e-cigarette). A follow-up visit will occur at week 12 to assess tobacco use status. The study aims are to (1) examine the impact of prohibiting menthol flavor in cigarettes and e-cigarettes on smoking behavior and (2) investigate whether outcomes differ by race to understand the impact of menthol policies on Black (vs. non-Black) individuals given high rates of menthol cigarette use in this population. The primary outcome will evaluate changes in the number of cigarettes smoked per day during the 8-week study period and will examine differences by regulatory scenario. Secondary outcomes will compare percent days smoke-free, changes in nicotine dependence, and motivation, confidence, and intentions to quit smoking by the regulatory scenarios. We will examine whether changes in the outcomes differ by Black vs. non-Black participants to compare the magnitude of the effect of the various menthol policy scenarios by race.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>Results will contribute critical information regarding menthol in cigarettes and e-cigarettes to inform regulatory policies that maximize reductions in cigarette smoking and reduce tobacco-related health disparities.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>NCT05259566. Yale IRB protocol #2000032211, last approved 12\/8\/2023.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12888-024-05619-0","type":"journal-article","created":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T20:04:04Z","timestamp":1710273844000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A randomized controlled trial of potential tobacco policies prohibiting menthol flavor in cigarettes and e-cigarettes: a study protocol"],"prefix":"10.1186","volume":"24","author":[{"given":"Krysten W.","family":"Bold","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akshika","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Haeny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralitza","family":"Gueorguieva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenia","family":"Buta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Baldassarri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren","family":"Lempert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suchitra","family":"Krishnan-Sarin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"O\u2019Malley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,12]]},"reference":[{"key":"5619_CR1","unstructured":"USDHHS. The health consequences of smoking\u201450 years of progress: a report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services. Volume 17. Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014."},{"key":"5619_CR2","unstructured":"World Health Organization. WHO global report: Mortality attributable to tobacco. 2012."},{"key":"5619_CR3","unstructured":"The NSDUH, Report. Recent Trends in Menthol Cigarette Use [press release]. November 18, 2011 2011."},{"issue":"Suppl 2","key":"5619_CR4","doi-asserted-by":"publisher","first-page":"ii14","DOI":"10.1136\/tobaccocontrol-2016-053329","volume":"25","author":"AC Villanti","year":"2016","unstructured":"Villanti AC, Mowery PD, Delnevo CD, Niaura RS, Abrams DB, Giovino GA. Changes in the prevalence and correlates of menthol cigarette use in the USA, 2004\u20132014. Tob Control. 2016;25(Suppl 2):ii14\u2013ii20.","journal-title":"Tob Control"},{"issue":"12","key":"5619_CR5","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1111\/add.12661","volume":"109","author":"SS Smith","year":"2014","unstructured":"Smith SS, Fiore MC, Baker TB. Smoking cessation in smokers who smoke menthol and non-menthol cigarettes. Addiction. 2014;109(12):2107\u201317.","journal-title":"Addiction"},{"issue":"7","key":"5619_CR6","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.2105\/AJPH.2011.300178","volume":"101","author":"DT Levy","year":"2011","unstructured":"Levy DT, Blackman K, Tauras J, Chaloupka FJ, Villanti AC, Niaura RS, et al. Quit attempts and quit rates among menthol and nonmenthol smokers in the United States. Am J Public Health. 2011;101(7):1241\u20137.","journal-title":"Am J Public Health"},{"issue":"2","key":"5619_CR7","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s13524-012-0159-z","volume":"50","author":"JY Ho","year":"2013","unstructured":"Ho JY, Elo IT. The contribution of smoking to black-white differences in US mortality. Demography. 2013;50(2):545\u201368.","journal-title":"Demography"},{"key":"5619_CR8","volume-title":"Advisory note: banning Menthol in Tobacco products","author":"World Health Organization Study Group on Tobacco Product Regulation","year":"2016","unstructured":"World Health Organization Study Group on Tobacco Product Regulation. Advisory note: banning Menthol in Tobacco products. Geneva, Switzerland: World Health Organization; 2016."},{"key":"5619_CR9","doi-asserted-by":"crossref","unstructured":"Kyriakos CN, Driezen P, Fong G, Chung-Hall J, Hyland A, Geboers C et al. Impact of the European Union\u2019s menthol cigarette ban on smoking cessation outcomes: longitudinal findings from the 2020\u20132021 ITC Netherlands surveys. Tob Control. 2022.","DOI":"10.1136\/tc-2022-057428"},{"issue":"4","key":"5619_CR10","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1136\/tobaccocontrol-2020-056259","volume":"31","author":"J Chung-Hall","year":"2022","unstructured":"Chung-Hall J, Fong GT, Meng G, Cummings KM, Hyland A, O\u2019Connor RJ, et al. Evaluating the impact of menthol cigarette bans on cessation and smoking behaviours in Canada: longitudinal findings from the Canadian arm of the 2016\u20132018 ITC Four Country smoking and vaping surveys. Tob Control. 2022;31(4):556\u201363.","journal-title":"Tob Control"},{"key":"5619_CR11","unstructured":"Tobacco. product standard for menthol in cigarettes, 87 FR 26454 (2022)."},{"key":"5619_CR12","volume-title":"Menthol cigarettes and public health: review of the scientific evidence and recommendations","author":"Tobacco Products Scientific Advisory Committee","year":"2011","unstructured":"Tobacco Products Scientific Advisory Committee. Menthol cigarettes and public health: review of the scientific evidence and recommendations. Washington DC: US Food and Drug Administration; 2011."},{"key":"5619_CR13","volume-title":"Preliminary scientific evaluation of the possible public health effects of menthol versus nonmenthol cigarettes","author":"FDA","year":"2013","unstructured":"FDA. Preliminary scientific evaluation of the possible public health effects of menthol versus nonmenthol cigarettes. Silver Spring, MD: Center for Tobacco Products, Food and Drug Administration; 2013."},{"issue":"7","key":"5619_CR14","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1111\/j.1360-0443.2012.03822.x","volume":"107","author":"RJ O\u2019Connor","year":"2012","unstructured":"O\u2019Connor RJ, Bansal-Travers M, Carter LP, Cummings KM. What would menthol smokers do if menthol in cigarettes were banned? Behavioral intentions and simulated demand. Addiction. 2012;107(7):1330\u20138.","journal-title":"Addiction"},{"issue":"5","key":"5619_CR15","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1001\/jamainternmed.2017.8650","volume":"178","author":"M Chaiton","year":"2018","unstructured":"Chaiton M, Schwartz R, Cohen JE, Soule E, Eissenberg T. Association of Ontario\u2019s ban on menthol cigarettes with smoking behavior 1 month after implementation. JAMA Intern Med. 2018;178(5):710\u20131.","journal-title":"JAMA Intern Med"},{"issue":"7","key":"5619_CR16","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.2105\/AJPH.2011.300179","volume":"101","author":"DT Levy","year":"2011","unstructured":"Levy DT, Pearson JL, Villanti AC, Blackman K, Vallone DM, Niaura RS, et al. Modeling the future effects of a menthol ban on smoking prevalence and smoking-attributable deaths in the United States. Am J Public Health. 2011;101(7):1236\u201340.","journal-title":"Am J Public Health"},{"key":"5619_CR17","doi-asserted-by":"crossref","unstructured":"Chaiton MO, Nicolau I, Schwartz R, Cohen JE, Soule E, Zhang B et al. Ban on menthol-flavoured tobacco products predicts cigarette cessation at 1 year: a population cohort study. Tob Control. 2019:tobaccocontrol\u20132018.","DOI":"10.1136\/tobaccocontrol-2018-054841"},{"issue":"1","key":"5619_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-020-09055-z","volume":"20","author":"CJ Cadham","year":"2020","unstructured":"Cadham CJ, Sanchez-Romero LM, Fleischer NL, Mistry R, Hirschtick JL, Meza R, et al. The actual and anticipated effects of a menthol cigarette ban: a scoping review. BMC Public Health. 2020;20(1):1\u201317.","journal-title":"BMC Public Health"},{"key":"5619_CR19","first-page":"624","volume":"29","author":"KW Bold","year":"2020","unstructured":"Bold KW, Jatlow P, Fucito LM, Eid T, Krishnan-Sarin S, O\u2019Malley S. Evaluating the effect of switching to non-menthol cigarettes among current menthol smokers: an empirical study of a potential ban of characterising menthol flavour in cigarettes. Tob Control. 2020;29:624\u201330.","journal-title":"Tob Control"},{"key":"5619_CR20","unstructured":"Tobacco product standard for characterizing flavors in cigars, 87 FR 26396. (2022)."},{"issue":"90","key":"5619_CR21","first-page":"28973","volume":"81","author":"FDA. Deeming Tobacco Products To Be Subject to the Federal Food","year":"2016","unstructured":"FDA. Deeming Tobacco Products To Be Subject to the Federal Food. Drug, and Cosmetic Act, as amended by the Family Smoking Prevention and Tobacco Control Act; restrictions on the sale and distribution of Tobacco products and Required Warning Statements for Tobacco Products. Final rule. Fed Regist. 2016;81(90):28973.","journal-title":"Fed Regist"},{"key":"5619_CR22","unstructured":"FDA finalizes enforcement policy on unauthorized flavored cartridge-based. e-cigarettes that appeal to children, including fruit and mint [press release]. 2020."},{"key":"5619_CR23","unstructured":"Administration FaD. Enforcement priorities for Electronic Nicotine Delivery Systems (ENDS) and Other Deemed Products on the Market Without Premarket Authorization (Revised). 2020. Report No.: FDA-2019-D-0661."},{"issue":"11","key":"5619_CR24","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1001\/jamapsychiatry.2021.2468","volume":"78","author":"F Hung","year":"2021","unstructured":"Hung F, Wallach JD, O\u2019Malley SS, Bold KW. Characteristics of registered clinical trials evaluating the role of e-Cigarettes in Cessation or reduction of cigarette smoking. JAMA Psych. 2021;78(11):1280\u20133.","journal-title":"JAMA Psych"},{"issue":"18","key":"5619_CR25","doi-asserted-by":"publisher","first-page":"475","DOI":"10.15585\/mmwr.mm7218a1","volume":"72","author":"ME Cornelius","year":"2023","unstructured":"Cornelius ME, Loretan CG, Jamal A, Lynn BCD, Mayer M, Alcantara IC, et al. Tobacco product use among adults\u2013United States, 2021. Morb Mortal Wkly Rep. 2023;72(18):475.","journal-title":"Morb Mortal Wkly Rep"},{"key":"5619_CR26","doi-asserted-by":"crossref","unstructured":"Gades MS, Alcheva A, Riegelman AL, Hatsukami DK. The role of nicotine and flavor in the abuse potential and appeal of electronic cigarettes for adult current and former cigarette and electronic cigarette users: a systematic review. Nicotine Tob Res. 2022:1\u201312.","DOI":"10.1093\/ntr\/ntac073"},{"issue":"6","key":"5619_CR27","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1111\/add.14936","volume":"115","author":"P Hajek","year":"2020","unstructured":"Hajek P, Pittaccio K, Pesola F, Myers Smith K, Phillips-Waller A, Przulj D. Nicotine delivery and users\u2019 reactions to Juul compared with cigarettes and other e\u2010cigarette products. Addiction. 2020;115(6):1141\u20138.","journal-title":"Addiction"},{"issue":"2","key":"5619_CR28","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1093\/ntr\/ntw160","volume":"19","author":"ML Goniewicz","year":"2017","unstructured":"Goniewicz ML, Gawron M, Smith DM, Peng M, Jacob P, Benowitz NL. Exposure to nicotine and selected toxicants in cigarette smokers who switched to electronic cigarettes: a longitudinal within-subjects observational study. Nicotine Tob Res. 2017;19(2):160\u20137.","journal-title":"Nicotine Tob Res"},{"key":"5619_CR29","doi-asserted-by":"crossref","unstructured":"Lindson N, Butler AR, McRobbie H, Bullen C, Hajek P, Begh R et al. Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev. 2024(1).","DOI":"10.1002\/14651858.CD010216.pub8"},{"key":"5619_CR30","doi-asserted-by":"crossref","unstructured":"Bold KW, Buta E, Simon P, Gueorguieva R, Jackson A, Suttiratana SC et al. Examining the potential role of e-cigarettes to reduce health disparities associated with menthol cigarette use: characterizing e-cigarette use, flavors, and reasons for use among US adults smoking menthol cigarettes. Drug Alcohol Depend. 2022:109475.","DOI":"10.1016\/j.drugalcdep.2022.109475"},{"issue":"3","key":"5619_CR31","doi-asserted-by":"publisher","first-page":"153","DOI":"10.18865\/ed.28.3.153","volume":"28","author":"MW Hooper","year":"2018","unstructured":"Hooper MW, Smiley SL. Comparison of e-cigarette use among menthol and non-menthol smokers: findings from a community based sample. Ethn Dis. 2018;28(3):153.","journal-title":"Ethn Dis"},{"issue":"9","key":"5619_CR32","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1093\/ntr\/ntac107","volume":"24","author":"M Kotlyar","year":"2022","unstructured":"Kotlyar M, Shanley R, Dufresne SR, Corcoran GA, Hatsukami DK. Effect on Tobacco Use and subjective measures of including E-cigarettes in a simulated Ban of Menthol in Combustible cigarettes. Nicotine Tob Res. 2022;24(9):1448\u201357.","journal-title":"Nicotine Tob Res"},{"issue":"9","key":"5619_CR33","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1093\/ntr\/ntz233","volume":"22","author":"DK Hatsukami","year":"2020","unstructured":"Hatsukami DK, Meier E, Lindgren BR, Anderson A, Reisinger SA, Norton KJ, et al. A randomized clinical trial examining the effects of instructions for electronic cigarette use on smoking-related behaviors and biomarkers of exposure. Nicotine Tob Res. 2020;22(9):1524\u201332.","journal-title":"Nicotine Tob Res"},{"issue":"14","key":"5619_CR34","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1056\/NEJMsa1502403","volume":"373","author":"EC Donny","year":"2015","unstructured":"Donny EC, Denlinger RL, Tidey JW, Koopmeiners JS, Benowitz NL, Vandrey RG, et al. Randomized trial of reduced-nicotine standards for cigarettes. N Engl J Med. 2015;373(14):1340\u20139.","journal-title":"N Engl J Med"},{"issue":"2","key":"5619_CR35","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1111\/j.1360-0443.2009.02780.x","volume":"105","author":"DK Hatsukami","year":"2010","unstructured":"Hatsukami DK, Kotlyar M, Hertsgaard LA, Zhang Y, Carmella SG, Jensen JA, et al. Reduced nicotine content cigarettes: effects on toxicant exposure, dependence and cessation. Addiction. 2010;105(2):343\u201355.","journal-title":"Addiction"},{"key":"5619_CR36","doi-asserted-by":"crossref","unstructured":"Mercincavage M, Souprountchouk V, Tang KZ, Dumont RL, Wileyto EP, Carmella SG et al. A randomized controlled trial of progressively reduced nicotine content cigarettes on smoking behaviors, biomarkers of exposure, and subjective ratings. Cancer Epidemiol Biomarkers Prev. 2016:cebp. 1088.2015.","DOI":"10.1158\/1055-9965.EPI-15-1088"},{"key":"5619_CR37","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1136\/tobaccocontrol-2018-054382","volume":"28","author":"J Huang","year":"2019","unstructured":"Huang J, Duan Z, Kwok J, Binns S, Vera LE, Kim Y, et al. Vaping versus JUULing: how the extraordinary growth and marketing of JUUL transformed the US retail e-cigarette market. Tob Control. 2019;28:146\u201351.","journal-title":"Tob Control"},{"key":"5619_CR38","unstructured":"Conway J. Vaping market share in the United States in 2020, by brand. 2020."},{"key":"5619_CR39","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.drugalcdep.2019.05.019","volume":"203","author":"N Nardone","year":"2019","unstructured":"Nardone N, Helen GS, Addo N, Meighan S, Benowitz NL. JUUL electronic cigarettes: Nicotine exposure and the user experience. Drug Alcohol Depend. 2019;203:83\u20137.","journal-title":"Drug Alcohol Depend"},{"issue":"e1","key":"5619_CR40","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1136\/tobaccocontrol-2016-053099","volume":"26","author":"J Brown","year":"2017","unstructured":"Brown J, DeAtley T, Welding K, Schwartz R, Chaiton M, Lawrence Kittner D, et al. Tobacco industry response to menthol cigarette bans in Alberta and Nova Scotia, Canada. Tob Control. 2017;26(e1):e71\u2013e4.","journal-title":"Tob Control"},{"issue":"5","key":"5619_CR41","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1136\/tobaccocontrol-2017-053910","volume":"27","author":"R Schwartz","year":"2018","unstructured":"Schwartz R, Chaiton M, Borland T, Diemert L. Tobacco industry tactics in preparing for menthol ban. Tob Control. 2018;27(5):577.","journal-title":"Tob Control"},{"issue":"2","key":"5619_CR42","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1037\/0893-164X.12.2.101","volume":"12","author":"RA Brown","year":"1998","unstructured":"Brown RA, Burgess ES, Sales SD, Whiteley JA, Evans DM, Miller IW. Reliability and validity of a smoking timeline follow-back interview. Psychol Addict Behav. 1998;12(2):101.","journal-title":"Psychol Addict Behav"},{"key":"5619_CR43","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.addbeh.2016.02.035","volume":"58","author":"MO Edelen","year":"2016","unstructured":"Edelen MO, Huang W, Stucky BD. Additional validity evidence for the PROMIS smoking assessment toolkit. Addict Behav. 2016;58:80\u20134.","journal-title":"Addict Behav"},{"issue":"11","key":"5619_CR44","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1016\/j.addbeh.2012.06.016","volume":"37","author":"MO Edelen","year":"2012","unstructured":"Edelen MO, Tucker JS, Shadel WG, Stucky BD, Cai L. Toward a more systematic assessment of smoking: development of a smoking module for PROMIS\u00ae. Addict Behav. 2012;37(11):1278\u201384.","journal-title":"Addict Behav"},{"issue":"11","key":"5619_CR45","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1093\/ntr\/ntx271","volume":"21","author":"M Morean","year":"2019","unstructured":"Morean M, Krishnan-Sarin S, Sussman S, Foulds J, Fishbein H, Grana R, et al. Psychometric evaluation of the E-cigarette dependence scale. Nicotine Tob Res. 2019;21(11):1556\u201364.","journal-title":"Nicotine Tob Res"},{"issue":"9","key":"5619_CR46","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1046\/j.1360-0443.2002.00198.x","volume":"97","author":"JF Etter","year":"2002","unstructured":"Etter JF, Sutton S. Assessing \u2018stage of change\u2019in current and former smokers. Addiction. 2002;97(9):1171\u201382.","journal-title":"Addiction"},{"issue":"10","key":"5619_CR47","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","volume":"166","author":"RL Spitzer","year":"2006","unstructured":"Spitzer RL, Kroenke K, Williams JB, L\u00f6we B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092\u20137.","journal-title":"Arch Intern Med"},{"issue":"9","key":"5619_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3928\/0048-5713-20020901-06","volume":"32","author":"K Kroenke","year":"2002","unstructured":"Kroenke K, Spitzer RL. The PHQ-9: a new depression diagnostic and severity measure. Psychiatric Annals. 2002;32(9):1\u20137.","journal-title":"Psychiatric Annals"},{"issue":"8","key":"5619_CR49","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1111\/j.1365-2850.2011.01735.x","volume":"18","author":"D Stevanovic","year":"2011","unstructured":"Stevanovic D. Quality of life enjoyment and satisfaction questionnaire\u2013short form for quality of life assessments in clinical practice: a psychometric study. J Psychiatr Ment Health Nurs. 2011;18(8):744\u201350.","journal-title":"J Psychiatr Ment Health Nurs"},{"issue":"6","key":"5619_CR50","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1037\/vio0000212","volume":"8","author":"MT Williams","year":"2018","unstructured":"Williams MT, Printz D, DeLapp RC. Assessing racial trauma with the trauma symptoms of discrimination scale. Psychol Violence. 2018;8(6):735.","journal-title":"Psychol Violence"},{"issue":"2","key":"5619_CR51","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1177\/074355489272003","volume":"7","author":"JS Phinney","year":"1992","unstructured":"Phinney JS. The multigroup ethnic identity measure: a new scale for use with diverse groups. J Adolesc Res. 1992;7(2):156\u201376.","journal-title":"J Adolesc Res"},{"issue":"1","key":"5619_CR52","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1037\/a0034749","volume":"61","author":"SD Brown","year":"2014","unstructured":"Brown SD, Unger Hu KA, Mevi AA, Hedderson MM, Shan J, Quesenberry CP, et al. The Multigroup ethnic identity Measure\u2014Revised: measurement invariance across racial and ethnic groups. J Couns Psychol. 2014;61(1):154.","journal-title":"J Couns Psychol"},{"issue":"Suppl 3","key":"5619_CR53","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1093\/ntr\/ntu032","volume":"16","author":"WG Shadel","year":"2014","unstructured":"Shadel WG, Edelen MO, Tucker JS, Stucky BD, Hansen M, Cai L. Development of the PrOMis\u00ae nicotine dependence item banks. Nicotine Tob Res. 2014;16(Suppl 3):190\u2013S201.","journal-title":"Nicotine Tob Res"},{"issue":"2","key":"5619_CR54","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1037\/0022-006X.72.2.139","volume":"72","author":"ME Piper","year":"2004","unstructured":"Piper ME, Piasecki TM, Federman EB, Bolt DM, Smith SS, Fiore MC, et al. A multiple motives approach to tobacco dependence: the Wisconsin Inventory of Smoking Dependence motives (WISDM-68). J Consult Clin Psychol. 2004;72(2):139.","journal-title":"J Consult Clin Psychol"},{"issue":"5","key":"5619_CR55","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1093\/ntr\/ntq032","volume":"12","author":"SS Smith","year":"2010","unstructured":"Smith SS, Piper ME, Bolt DM, Fiore MC, Wetter DW, Cinciripini PM, et al. Development of the brief Wisconsin inventory of smoking dependence motives. Nicotine Tob Res. 2010;12(5):489\u201399.","journal-title":"Nicotine Tob Res"},{"issue":"9","key":"5619_CR56","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1111\/j.1360-0443.1991.tb01879.x","volume":"86","author":"TF Heatherton","year":"1991","unstructured":"Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom K. The Fagerstr\u00f6m test for nicotine dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict. 1991;86(9):1119\u201327.","journal-title":"Br J Addict"},{"issue":"5","key":"5619_CR57","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.addbeh.2006.06.028","volume":"32","author":"JC Cappelleri","year":"2007","unstructured":"Cappelleri JC, Bushmakin AG, Baker CL, Merikle E, Olufade AO, Gilbert DG. Confirmatory factor analyses and reliability of the modified cigarette evaluation questionnaire. Addict Behav. 2007;32(5):912\u201323.","journal-title":"Addict Behav"},{"key":"5619_CR58","doi-asserted-by":"crossref","unstructured":"Morean ME, Bold KW, The Modified E-cigarette Evaluation questionnaire: psychometric evaluation of an adapted version of the modified cigarette evaluation questionnaire for Use with adults who Use Electronic Nicotine Delivery systems. Nicotine Tob Res. 2022; 24(9), 1396\u20131404.","DOI":"10.1093\/ntr\/ntac062"},{"issue":"1\u20132","key":"5619_CR59","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s00213-004-1923-6","volume":"177","author":"R West","year":"2004","unstructured":"West R, Hajek P. Evaluation of the mood and physical symptoms scale (MPSS) to assess cigarette withdrawal. Psychopharmacology. 2004;177(1\u20132):195\u20139.","journal-title":"Psychopharmacology"},{"issue":"2","key":"5619_CR60","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1037\/0893-164X.21.2.216","volume":"21","author":"BA Toll","year":"2007","unstructured":"Toll BA, O\u2019Malley SS, McKee SA, Salovey P, Krishnan-Sarin S. Confirmatory factor analysis of the Minnesota nicotine withdrawal scale. Psychol Addict Behav. 2007;21(2):216.","journal-title":"Psychol Addict Behav"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-024-05619-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-024-05619-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-024-05619-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T20:10:12Z","timestamp":1710274212000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-024-05619-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,12]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5619"],"URL":"https:\/\/doi.org\/10.1186\/s12888-024-05619-0","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,12]]},"assertion":[{"value":"21 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for the human subjects procedures of this trial was obtained from the Yale University Institutional Review Board Human Investigation Committee (HIC approval #2000032211). Consent to participate will be obtained from participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"There are no conflicts of interest or competing interests related to this work. Unrelated to the submitted work, Dr. O\u2019Malley reports being a member of the American Society of Clinical Psychopharmacology\u2019s (ASCP\u2019s) Alcohol Clinical Trials Initiative, supported by Alkermes, Dicerna, Ethypharm, Lundbeck, Otsuka, Pear Therapeutics, Kinnov Therapeutics; Consultant\/advisory board member, Alkermes, Dicerna; patent application with Novartis and Yale; DSMB member for NIDA Clinical Trials Network. Dr. Gueorguieva reports Royalties from Taylor & Francis for an academic book.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"201"}}